Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Type

Guidance programme

HealthTech approach

HealthTech approach

Advice programme

Area of interest

Showing 1601 to 1625 of 2559

Published guidance, NICE advice and quality standards
TitleReference numberPublishedLast updated
HumiGard for preventing inadvertent perioperative hypothermiaHTG428
eazyplex SuperBug kits for detecting carbapenemase-producing organismsMIB94
Osteoporosis: assessing the risk of fragility fractureCG146
Stable anginaQS21
Ibrutinib for previously treated chronic lymphocytic leukaemia and untreated chronic lymphocytic leukaemia with 17p deletion or TP53 mutationTA429
Sofosbuvir–velpatasvir for treating chronic hepatitis CTA430
Cerebral palsy in under 25s: assessment and managementNG62
Antimicrobial stewardship: changing risk-related behaviours in the general populationNG63
Boston Keratoprosthesis Type I for corneal blindnessMIB91
CentriMag for heart failureMIB92
Ekso exoskeleton for rehabilitation in people with neurological weakness or paralysisMIB93
Refractory extrapulmonary sarcoidosis: infliximabES4
Smartinhaler for asthmaMIB90
Pomalidomide for multiple myeloma previously treated with lenalidomide and bortezomibTA427
TuberculosisQS141
Learning disability: identifying and managing mental health problemsQS142
Extracorporeal shockwave therapy for Achilles tendinopathyHTG426
Radiation therapy for early Dupuytren's diseaseHTG427
Dasatinib, nilotinib and high-dose imatinib for treating imatinib-resistant or intolerant chronic myeloid leukaemiaTA425
Dasatinib, nilotinib and imatinib for untreated chronic myeloid leukaemiaTA426
Everolimus with exemestane for treating advanced breast cancer after endocrine therapyTA421
Crizotinib for previously treated anaplastic lymphoma kinase-positive advanced non-small-cell lung cancerTA422
Eribulin for treating locally advanced or metastatic breast cancer after 2 or more chemotherapy regimensTA423
Pertuzumab for the neoadjuvant treatment of HER2-positive breast cancerTA424
Organ donation for transplantation: improving donor identification and consent rates for deceased organ donationCG135

Results per page

  1. 10
  2. 25
  3. 50
  4. All